Patterns of Care/Quality of Care Study: Diagnosis Year 2013 (SEER)Period of Performance: 08/15/2014-08/14/2015Line item #: 1
护理模式/护理质量研究:2013 年诊断 (SEER) 执行期间:08/15/2014-08/14/2015行项目
基本信息
- 批准号:8928277
- 负责人:
- 金额:$ 11.67万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-08-15 至 2015-08-14
- 项目状态:已结题
- 来源:
- 关键词:Acute Lymphocytic LeukemiaAdjuvant TherapyAdoptedAgeBedsBiological MarkersCancer PatientCharacteristicsCommunitiesComorbidityDataDiagnosisDiagnostic testsDivision of Cancer Control and Population SciencesEducational process of instructingEthnic OriginFemale Breast CarcinomaGeographic LocationsHodgkin DiseaseHospitalsImmunotherapyInsurance CoverageLawsLinkMalignant NeoplasmsMedicareNational Cancer InstituteNon-Hodgkin&aposs LymphomaOperative Surgical ProceduresPatientsPatternPatterns of CarePerformancePhysiciansQuality of CareRaceRadiation therapyReportingTimeUnited StatesWorkcancer sitecancer therapychemotherapyclinical practicehormone therapysarcomasex
项目摘要
SEER Patterns of Care Studies describe, characterize, and compare practice patterns and treatments provided for cancer in different geographic areas of the United States. SEER Patterns of Care/Quality of Care Studies are conducted to satisfy a Congressional directive (under Public Law 100-607, Sec. 413 (a)(2)(C) adopted November 4, 1988) to the National Cancer Institute to “assess the incorporation of state-of-the-art cancer treatments into clinical practice and the extent to which cancer patients receive such treatments and include the results of such assessment in the biennial reports…”. To select the cancers to satisfy this directive, the Division of Cancer Control and Population Sciences has been working closely with the Division of Cancer Treatment. This year’s Pattern’s of Care (POC) Study shall investigate state-of-the-art therapies for patients with cancers of sites: sarcoma for all ages and for ages 15-39 non-Hodgkin lymphoma, Hodgkin lymphoma, acute lymphocytic leukemia and female breast cancer.
SEER模式护理研究描述,表征和比较美国不同地理区域的癌症实践模式和治疗方法。SEER护理模式/护理质量研究是为了满足国会指令(根据公法100-607,第100-607节)。413(a)(2)(C),1988年11月4日通过),以国家癌症研究所“评估最先进的癌症治疗纳入临床实践和癌症患者接受此类治疗的程度,并将此类评估的结果纳入两年期报告."。为了选择符合这一指令的癌症,癌症控制和人口科学司一直与癌症治疗司密切合作。今年的护理模式(POC)研究将调查癌症患者的最新疗法:所有年龄段和15-39岁的非霍奇金淋巴瘤,霍奇金淋巴瘤,急性淋巴细胞白血病和女性乳腺癌。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
THOMAS TUCKER其他文献
THOMAS TUCKER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('THOMAS TUCKER', 18)}}的其他基金
SEER-LINKED VIRTUAL TISSUE REPOSITORY (VTR) PROGRAM
SEER 链接虚拟组织存储库 (VTR) 计划
- 批准号:
10976186 - 财政年份:2023
- 资助金额:
$ 11.67万 - 项目类别:
NCI SEER-LINKED PEDIATRIC WHOLE SLIDE IMAGING (POP: 8/17/2020 - 8/16/2021)
NCI SEER 关联儿科全切片成像(POP:2020 年 8 月 17 日 - 2021 年 8 月 16 日)
- 批准号:
10272821 - 财政年份:2020
- 资助金额:
$ 11.67万 - 项目类别:
IGF::OT::IGF 402 - NORTH AMERICAN ASSOCIATION OF CENTRAL CANCER REGISTRIES, INC. (NAACCR); TECHNICAL SUPPORT FOR CANCER SURVEILLANCE; POP 07/01/2014-06/30/2014
IGF::OT::IGF 402 - 北美中央癌症登记协会 (NAACCR);
- 批准号:
8885293 - 财政年份:2014
- 资助金额:
$ 11.67万 - 项目类别:
TAS::75 0849::TAS SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) PROGRAM
TAS::75 0849::TAS 监测、流行病学和最终结果 (SEER) 计划
- 批准号:
8522048 - 财政年份:2012
- 资助金额:
$ 11.67万 - 项目类别:
Patterns of Care (POC) Quality of Care Dx Yr 2011
护理模式 (POC) 护理质量 Dx 2011 年
- 批准号:
8565231 - 财政年份:2012
- 资助金额:
$ 11.67万 - 项目类别:
TAS::75 0849::TAS SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) PROGRAM
TAS::75 0849::TAS 监测、流行病学和最终结果 (SEER) 计划
- 批准号:
8317499 - 财政年份:2011
- 资助金额:
$ 11.67万 - 项目类别:
TAS::75 0849::TAS SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) PROGRAM
TAS::75 0849::TAS 监测、流行病学和最终结果 (SEER) 计划
- 批准号:
8317500 - 财政年份:2011
- 资助金额:
$ 11.67万 - 项目类别:
SEER RRSS Using Multiple Imputation to Enhance the Utility of SEER Summary Stage
SEER RRSS 使用多重插补增强 SEER 摘要阶段的实用性
- 批准号:
8351006 - 财政年份:2011
- 资助金额:
$ 11.67万 - 项目类别:
TAS::75 0849::TAS SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) PROGRAM
TAS::75 0849::TAS 监测、流行病学和最终结果 (SEER) 计划
- 批准号:
8131535 - 财政年份:2010
- 资助金额:
$ 11.67万 - 项目类别:
TAS::75 0849::TAS SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) PROGRAM
TAS::75 0849::TAS 监测、流行病学和最终结果 (SEER) 计划
- 批准号:
8163679 - 财政年份:2010
- 资助金额:
$ 11.67万 - 项目类别:
相似海外基金
Countering sympathetic vasoconstriction during skeletal muscle exercise as an adjuvant therapy for DMD
骨骼肌运动期间对抗交感血管收缩作为 DMD 的辅助治疗
- 批准号:
10735090 - 财政年份:2023
- 资助金额:
$ 11.67万 - 项目类别:
The ESCAPE clinical trial of circulating tumor DNA to guide adjuvant therapy in chemo-resistant triple negative breast cancer
循环肿瘤 DNA 指导化疗耐药三阴性乳腺癌辅助治疗的 ESCAPE 临床试验
- 批准号:
494901 - 财政年份:2023
- 资助金额:
$ 11.67万 - 项目类别:
Operating Grants
A Type I Hybrid Effectiveness-Implementation Trial to Evaluate a Navigation-Based Multilevel Intervention to Decrease Delays Starting Adjuvant Therapy Among Patients with Head and Neck Cancer
一项 I 型混合有效性实施试验,用于评估基于导航的多级干预措施,以减少头颈癌患者开始辅助治疗的延迟
- 批准号:
10714537 - 财政年份:2023
- 资助金额:
$ 11.67万 - 项目类别:
Multi-modal machine learning to guide adjuvant therapy in surgically resectable colorectal cancer
多模式机器学习指导可手术切除结直肠癌的辅助治疗
- 批准号:
10588103 - 财政年份:2023
- 资助金额:
$ 11.67万 - 项目类别:
Efficacy of ethanol adjuvant therapy after resection of malignant soft tissue tumors
恶性软组织肿瘤切除术后乙醇辅助治疗的疗效
- 批准号:
22K09407 - 财政年份:2022
- 资助金额:
$ 11.67万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of immune response cells and development of novel adjuvant therapy for sublingual immunotherapy
免疫应答细胞的鉴定和舌下免疫治疗新型辅助疗法的开发
- 批准号:
21KK0287 - 财政年份:2022
- 资助金额:
$ 11.67万 - 项目类别:
Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))
Pursuing molecular biomarkers to guide adjuvant therapy for HPV+ head and neck cancers after transoral robotic surgery
寻找分子生物标志物来指导经口机器人手术后 HPV 头颈癌的辅助治疗
- 批准号:
10357120 - 财政年份:2022
- 资助金额:
$ 11.67万 - 项目类别:
Biomarker research using two prospective studies on preoperative and postoperative adjuvant therapy for pancreatic cancer
使用两项关于胰腺癌术前和术后辅助治疗的前瞻性研究进行生物标志物研究
- 批准号:
21K08700 - 财政年份:2021
- 资助金额:
$ 11.67万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Personalized Resistant Starch as an Adjuvant Therapy for Pediatric Inflammatory Bowel Disease
个性化抗性淀粉作为小儿炎症性肠病的辅助治疗
- 批准号:
437315 - 财政年份:2020
- 资助金额:
$ 11.67万 - 项目类别:
Studentship Programs
Tailored adjuvant therapy in POLE-mutated and p53-wildtype early stage endometrial cancer (TAPER)
POLE 突变和 p53 野生型早期子宫内膜癌 (TAPER) 的定制辅助治疗
- 批准号:
435603 - 财政年份:2020
- 资助金额:
$ 11.67万 - 项目类别:
Operating Grants